Cardiac Biotech Solutions, Inc. (CBSC)
0.04
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Cardiac Biotech Solutions Debt to Equity Ratio : -0.2375 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2375 |
| March 31, 2026 | -0.2343 |
| December 31, 2025 | -0.2174 |
| September 30, 2025 | -0.2021 |
| June 30, 2025 | -0.17 |
| March 31, 2025 | -0.1344 |
| December 31, 2024 | -0.1185 |
| September 30, 2024 | -0.1237 |
| June 30, 2024 | -0.029 |
| March 31, 2024 | -0.0325 |
| December 31, 2023 | -0.0872 |
| September 30, 2023 | -0.1495 |
| June 30, 2023 | -0.1811 |
| March 31, 2023 | -0.2653 |
| December 31, 2022 | -0.8489 |
| September 30, 2022 | 1.169 |
| June 30, 2022 | 0.9529 |
| March 31, 2022 | 0.0896 |
| December 31, 2021 | 0.0513 |
| September 30, 2021 | -1.981 |
| Date | Value |
|---|---|
| June 30, 2021 | -2.020 |
| March 31, 2021 | -2.047 |
| December 31, 2020 | 0.0128 |
| September 30, 2020 | 0.0092 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.9151 |
| December 31, 2019 | |
| June 30, 2019 | -0.3321 |
| March 31, 2019 | -0.3457 |
| December 31, 2018 | -0.314 |
| September 30, 2018 | -0.3418 |
| June 30, 2018 | -0.2474 |
| March 31, 2018 | -0.4234 |
| December 31, 2017 | -0.4916 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.4754 |
| December 31, 2016 | 0.2962 |
| September 30, 2016 | 0.3149 |
| June 30, 2016 | 0.0778 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Vyome Holdings, Inc. | 0.0029 |
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.5053M |
| Total Liabilities (Quarterly) | 2.726M |
| Shareholders Equity (Quarterly) | -2.221M |
| Current Ratio | 0.2327 |
| Net Debt Paydown Yield | -1.03% |